Abstract
The inhibition of protein tyrosine phosphatase 1B (PTP1B) is of substantial interest for the treatment of type-2 diabetes mellitus. Using an in vitro enzyme assay with human recombinant PTP1B 1,2,3,4,6-penta-O-galloyl-D-glucopyranose was isolated from the roots of Paeonia lactiflora as an inhibitor of PTP1B, with an IC(50) value of 4.8 μM. Additionally, 1 was shown to act as an insulin sensitizer in human hepatoma cells (HCC-1.2) at a concentration of 10 μM. Thus, a potential new mechanism of action is provided explaining the antidiabetic properties of P. lactiflora.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Austria
-
Carcinoma, Hepatocellular / metabolism
-
Diabetes Mellitus, Type 2 / drug therapy
-
Enzyme Assays
-
Humans
-
Hydrolyzable Tannins / chemistry
-
Hydrolyzable Tannins / isolation & purification*
-
Hydrolyzable Tannins / pharmacology*
-
Hypoglycemic Agents / chemistry
-
Hypoglycemic Agents / isolation & purification*
-
Hypoglycemic Agents / pharmacology*
-
Insulin / metabolism
-
Paeonia / chemistry*
-
Plant Roots / chemistry
-
Plants, Medicinal / chemistry*
-
Protein Tyrosine Phosphatase, Non-Receptor Type 1 / antagonists & inhibitors*
Substances
-
Hydrolyzable Tannins
-
Hypoglycemic Agents
-
Insulin
-
pentagalloylglucose
-
Protein Tyrosine Phosphatase, Non-Receptor Type 1